Covestor Ltd Reduces Position in ICU Medical, Inc. (NASDAQ:ICUI)

Covestor Ltd decreased its position in shares of ICU Medical, Inc. (NASDAQ:ICUI) by 9.8% during the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 780 shares of the medical instruments supplier’s stock after selling 85 shares during the quarter. Covestor Ltd’s holdings in ICU Medical were worth $142,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in the business. Allworth Financial LP grew its holdings in ICU Medical by 100.0% in the third quarter. Allworth Financial LP now owns 200 shares of the medical instruments supplier’s stock worth $36,000 after purchasing an additional 100 shares during the last quarter. Xponance Inc. grew its holdings in shares of ICU Medical by 6.0% during the second quarter. Xponance Inc. now owns 1,977 shares of the medical instruments supplier’s stock valued at $235,000 after buying an additional 112 shares during the last quarter. Equitable Trust Co. increased its position in shares of ICU Medical by 2.2% in the 3rd quarter. Equitable Trust Co. now owns 5,213 shares of the medical instruments supplier’s stock valued at $950,000 after acquiring an additional 112 shares during the period. CWM LLC raised its stake in shares of ICU Medical by 18.5% in the second quarter. CWM LLC now owns 767 shares of the medical instruments supplier’s stock worth $91,000 after purchasing an additional 120 shares during the last quarter. Finally, Hexagon Capital Partners LLC lifted its holdings in shares of ICU Medical by 162.7% during the third quarter. Hexagon Capital Partners LLC now owns 197 shares of the medical instruments supplier’s stock worth $36,000 after purchasing an additional 122 shares during the period. Institutional investors own 96.10% of the company’s stock.

ICU Medical Stock Up 0.8 %

Shares of ICUI opened at $178.27 on Tuesday. ICU Medical, Inc. has a one year low of $79.85 and a one year high of $188.53. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.08 and a current ratio of 2.41. The stock has a 50 day moving average price of $175.56 and a 200 day moving average price of $141.16. The stock has a market capitalization of $4.35 billion, a price-to-earnings ratio of -61.05 and a beta of 0.66.

Wall Street Analysts Forecast Growth

ICUI has been the subject of a number of recent research reports. Needham & Company LLC reissued a “hold” rating on shares of ICU Medical in a research report on Thursday, October 10th. Jefferies Financial Group started coverage on ICU Medical in a research report on Monday, October 14th. They set a “hold” rating and a $183.00 price target for the company. StockNews.com raised shares of ICU Medical from a “hold” rating to a “buy” rating in a report on Thursday, September 12th. Raymond James raised their target price on ICU Medical from $158.00 to $190.00 and gave the company an “outperform” rating in a research report on Thursday, September 12th. Finally, KeyCorp raised their price objective on ICU Medical from $147.00 to $198.00 and gave the company an “overweight” rating in a report on Tuesday, October 15th. Two investment analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $170.25.

Insider Activity

In other news, CEO Vivek Jain sold 12,000 shares of the business’s stock in a transaction that occurred on Friday, August 16th. The stock was sold at an average price of $156.04, for a total transaction of $1,872,480.00. Following the transaction, the chief executive officer now directly owns 104,593 shares in the company, valued at $16,320,691.72. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. In other ICU Medical news, CEO Vivek Jain sold 12,000 shares of the business’s stock in a transaction dated Friday, August 16th. The shares were sold at an average price of $156.04, for a total value of $1,872,480.00. Following the transaction, the chief executive officer now directly owns 104,593 shares in the company, valued at $16,320,691.72. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, VP Daniel Woolson sold 2,502 shares of the firm’s stock in a transaction on Friday, August 30th. The stock was sold at an average price of $163.22, for a total value of $408,376.44. Following the sale, the vice president now directly owns 13,107 shares of the company’s stock, valued at approximately $2,139,324.54. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 50,502 shares of company stock worth $8,445,976 over the last three months. Insiders own 6.70% of the company’s stock.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.